首页> 外国专利> A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130

A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130

机译:包含GP 130的激素复合物的激素替代药物的选择方法

摘要

It has been found that the ligands of the group of cytokinssimilar to Interleukin 6 (IL-6), that is Oncostatin M (OSM), LeukemiaInhibitory Factor (LIF), Ciliary Neurotrophic Factor (CNTF) andInterleukin 11 (IL-11), induce formation of a receptor complexof which the membrane molecule gp 130 is a part. It is thuspossible to formulate the hypothesis that two different surfaces ofthe protein (in this class of hormones), known as site 1 and site 2bind to two different molecules: site 1 to the specific receptor andsite 2 to gp 130. The invention allows the identification of thesesites and the isolation of variants having, with respect to the wildhormone, a greater affinity for the specific receptor (superagonistsand superantagonists) or affinity for gp 130 reduced or abolished(antagonists and superantagonists). The figure shows the constructpHen.DELTA. hIL-6 and the production of phasmidic particles that can beused to select agonists of Interleukin 6.
机译:已经发现细胞因子组的配体类似于白细胞介素6(IL-6),即Oncostatin M(OSM),白血病抑制因子(LIF),睫状神经营养因子(CNTF)和白介素11(IL-11),诱导受体复合物的形成膜分子gp 130是其中的一部分。因此可以提出以下假设:蛋白质(在这类激素中),称为部位1和部位2与两个不同的分子结合:位点1与特定受体结合位点2到gp130。本发明可以识别这些位点位点和野生变异的隔离激素,对特定受体的亲和力更高(超激动剂和超级拮抗剂)或对gp 130的亲和力降低或取消(拮抗剂和超拮抗剂)。该图显示了构造pH值Δ hIL-6和可能是用于选择白介素6的激动剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号